Introduction: The aim of this study was to explore the prevalence and predictors of
| INTRODUC TI ON
The cesarean section (CS) rate is rising worldwide especially in China due to the prevalence of maternally requested cesarean deliveries and the 30-year-long national one-child policy.
1 Over the last 3 years, with the implementation of a new national family planning policy, millions of women with a history of CS are becoming expectant mothers. 2 The cesarean scar defect (CSD), which is only present after a CS, is defined as myometrial discontinuity at the CS scar site with a sonographically visible indentation in the myometrium of at least 2 mm (also called a "niche" by many researchers). 3 CSD is associated with abnormal uterine bleeding (75%-82%), postmenstrual spotting (29%-34%), cesarean scar ectopic pregnancies (1 : 1800-1 : 2216)
and infertility (32/92). 3, 4 Uterine dehiscence, uterine rupture, cesarean scar pregnancy, and morbidly adherent placenta are also associated with CSD.
5,6
Prevalence of CSD with transvaginal ultrasonography (TVU) is 24%-88% in Europe. 4 In recent years, the CSD problem has caught the attention and raised concern around the world, but there is no guideline for prevention of or intervention in CSD because its natural history has not been fully clarified.
China has > 20% of the world's population with over 7 million CSs carried out nationwide yearly. However, no data on CSD prevalence have ever been reported, to the best of our knowledge. Thousands of women with CSD with various complications seek treatment and many women die of uterine rupture or cesarean scar pregnancy, which causes a huge burden on the medical system. China is therefore in great need of methods to evaluate and manage CSD.
The prevalence of CSD varies among different diagnostic techniques and with interval after CS. Research into the prevalence of CSD using TVU showed a wide range. Previous reviews showed that the prevalence of CSD on TVU was 7%~88%. 4, 7 Only two studies described CSD prevalence at 6 weeks postpartum, the results were 49.6% (sample size = 263) and 43% (sample size = 53) CSD with TVU. 8, 9 Until now, most CSD risk factor studies focused on surgery-related factors of wound healing, such as incision location, adhesions, incomplete uterine closure, uterine suture technique-like single-layer vs double-layer uterine closure, or including vs excluding the endometrial layer at CS. [10] [11] [12] However, scant attention has been paid to patient-related factors, such as coagulation and presence of infection, which may potentially affect wound healing.
This prospective cohort study assessed the prevalence of CSD and evaluated both surgical and patient-related risk factors. We hypothesized that the Chinese population may have a similar prevalence of CSD as do European countries and that patient-related factors would be important pathogenic factors in uterine wound healing.
| MATERIAL AND ME THODS
Women between 34 and 42 weeks of gestation scheduled for CS from October 2016 to May 2017 were screened for eligibility.
The exclusion criteria were the following. All patients underwent a double-layer uterine suture in the closing of the uterine incision: the first layer including (full-thickness suturing) or excluding (split suturing) the decidua in the total myometrial suture and second layer with the upper one-third of the myometrium and the perimetrium. 10, 13 The suturing method was based on the obstetrician's preference.
| Primary outcome
Transvaginal ultrasonography was applied to detect and measure CSD 6 weeks postpartum according to the referenced method. 
| Data collection and coding
We recorded demographic characteristics (age, gestational age, body mass index), reproductive history, perinatal complications, and blood routine (taken before and within 24 h post-CS), as well as coagulation functions and fibrinogen levels (these are routinely gathered before CS).
Intraoperative data included indications for CS, cervical dilation, premature rupture of membranes (PROM) and its associated duration, amniotic fluid-related factors, fetal birthweight (weights were summed for twins), intrauterine microbiology (in some participants), CS duration, and suturing technique (including or excluding the decidua).
Postoperative data included blood routine, maximum body temperature-monitored for at least 3 days, 4-hourly to 6-hourly; temperature was defined as normal (< 37.5°C), subfebrile (37.5-38.0°C), or fever (≥ 38.0°C). Type and dosage of administered antibiotics were recorded. Antibiotics were administered according to Chinese management guidelines. In participants with gestational hypertensive disease, we noted which antihypertensive agents were administered postpartum.
| Statistical analyses
We conducted a pilot study and estimated the prevalence of CSD to be 40% (16/40) when evaluating the sample. Our cohort sample size was generated by PASS 11 (NCSS LLC., Kaysville, UT, USA) with a confidence level of 0.975 and a confidence interval of 0.10. The total sample size was 525 to allow a 5% dropout rate. The chi-squared test,
Fisher's exact test, t test, and one-way analysis of variance test were applied to compare differences between groups. Variables associated with CSD on univariate analysis (P < 0.20) were included as predictors in multivariable binary logistic regression analysis using the backward conditional method (stepwise removal probability of 0.10). Tests for trend were performed by entering ordinal variables into the regression model to detect their trend association with CSD occurrence. All analyses were performed in SPSS, version 22.0 (IBM, Armonk, NY, USA). A two-sided P < 0.05 was considered statistically significant. 
| Ethical approval

| RE SULTS
There were 1018 eligible women, including 671 scheduled for selective CS from outpatient service and 347 emergency CS from the labor room. Of them, 125 were ineligible and 306 declined to participate, 587
women gave consent while 59 finally succeeded in having a vaginal delivery. Of the 528 women who gave informed consent and underwent the CS, four suffered from incision lacerations and 10 missed the 6-week TVU follow up. Finally, 514 women were included in the cohort.
( Figure 2 ) Of the 514 women, 80 had a previous pregnancy, of whom 22 (4.3%) had a previous vaginal delivery and 58 (11.3%) had a previous CS. The mean maternal age was 31.9 ± 4.0 years, and pregestational and prenatal body mass indices were 21.3 ± 3.2 and 26.7 ± 3.5 kg/ m 2 , respectively. Univariate analysis revealed baseline demographic data among CSD and NCSD groups to be equal with 12 variates with P < 0.200 (as showed in Table 1 ) as candidate predictors for CSD in further multivariate regression analysis. Patients with a hypertensive disorder in pregnancy were followed up for 12 weeks postpartum to establish a definitive diagnosis. The presence of hypertensive disorder was not correlated with occurrence of CSD (P = 0.245), but antihypertensive drug administration post-CS was found to produce a significant difference (P = 0.042).
| Prevalence and risk factors
Furthermore, treatment with a calcium-channel blocker (nifedipine) was associated with a higher CSD prevalence compared with treat- 
| Antibiotics and CSD
The subgroup treated with multiple doses of perioperative antibiotics was found to have a significantly lower CSD prevalence than the single-dose subgroup (aOR 0.4, 95% CI 0.3-0.7, P < 0.001).
Furthermore, the single-dose cefuroxime subgroup (n = 190) was found to have a significantly lower CSD prevalence than the singledose cefradine subgroup (n = 162) (38.9%, 95% CI 34.7%-48.6% vs 56.8%, 95% CI 51.3%-66.7%; aOR 0.5, 95% CI 0.3-0.8, P = 0.006).
Patients who received more doses of cefuroxime were found to have an even lower rate of CSD manifestation (dosage effect P trend = 0.034) in the subgroup of patients given only cefuroxime (n = 239). (Table 2 ) Table 3 shows the factors most relevant to administration of multiple doses of antibiotics after adjustment for variable including PROM, pre-/post-CS hemoglobin, post-CS platelet count, pre-CS fibrinogen, and prenatal body mass index using the multivariate regression model. The fever post-CS (4.1-fold, 95% CI 2.2-7.8, greater than normal), intrapartum infection (3.3-fold, 95% CI 1.7-6.6, greater than non-infection), emergency CS (2.0-fold, 95% CI 1.3-3.0, greater than elective CS), and cervical dilation ≥ 3 cm (2.2-fold, 95% CI 1.2-3.9, greater than the dilation< 3 cm) were considered to be the main predictors of multi-dose antibiotics management.
| D ISCUSS I ON
In this prospective cohort, 43.4% (95% CI 39.1%-47.7%) of Chinese participants were found to have CSD under TVU approximately 6 weeks post-CS, which is similar to data previously reported from European participants. Post-CS fever (≥ 38°C) and subfebrile temperatures (37.5-38.0°C)
significantly increased the risk of CSD, whereas multi-dose antibiotic administration was found to be a protective factor against CSD manifestation. Low platelets post-CS and high fibrinogen level pre-CS both predicted the occurrence of CSD.
Although our study population was recruited from a single center, we not only collected data on previously reported risk factors, such as suturing techniques and uterus position, but also focused 
TA B L E 1 (Continued)
on clinical characteristics that play important roles in the promotion of CSD, such as infection and perioperative pharmacologic management. Such patient-related factors, infection in particular, as well as associated physiologic complications of pregnancy (eg hypercoagulability) are crucial influences on the development of CSD that were largely glossed over to date.
We applied initial CSD measurement about 6 weeks postpartum focusing on an early wound healing assessment and clinical follow up. The wound healing of the uterine cesarean incision is not fully understood and the natural developmental processes of CSD through time are still unclear, so the uterine scar and CSD may change over time. One prospective observational study showed consistence of the CSD from 6 weeks to 6 months and even longer. Another prospective study showed that in some women the presence or absence of CSD may reverse from 6 weeks to 6 months.
15
Another cross-sectional study showed that the prevalence of CSD varies with time (3-12 months, 1-5 years, 5-10 years after CS). 16 So, the prevalence of CSD at different times post-CS needs to be investigated in the future.
Most early studies on CSD were based on transvaginal ultrasound scans, but later studies showed saline-contrast sonohysterography to be more sensitive and reliable. [17] [18] [19] [20] We performed TVU for every woman without sonohysterography. So, our result of CSD prevalence may be underestimated. About 15% of women at 6 weeks post-CS still had lochia, which could be considered as contrast medium in the uterus. The lochia would make the CSD more likely to be detected. Therefore, a further study is needed to find an optimal time point and more reliable diagnostic techniques for CSD assessment.
Antibiotic prophylaxis prevents a variety of serious post-CS infectious complications. 21 Our study is the first to indicate that post-CS infection plays an important role in the pathogenesis of CSD. Participants in our study who had subfebrile temperatures (37.5°C-38.0°C) required as much serious clinical management as did pyretic patients (≥ 38.0°C) because they were at high risk of CSD but received inadequate antibiotics. Cefuroxime covers more
Gram-negative bacteria (eg Escherichia coli and Enterobacteriaceae)
than do first-generation cephalosporins. 22 Guidelines regarding management of post-CS infections and prophylactic antibiotics were mainly focused on obvious short-term outcomes like endometritis and wound infections. Our study, however, underscores a correlation between infection and CSD. As we only evaluated for a nonspecific history of infection by evaluating body temperature, white blood cell counts and C-reactive protein, future studies should focus on investigating a potential specific causal relation between infection and CSD.
In this study, single-dose antibiotic options were cefradine (a first-generation cephalosporin) and cefuroxime (a second-generation cephalosporin) or clindamycin in the event of cephalosporin allergy. Cefuroxime was more commonly administered in settings associated with infection (eg PROM). Extra doses of adjunctive or therapeutic antibiotics were administered to patients with factors The factors with P value <0.20 in Table 1 were included in the logistic regression model, the odds ratios (aOR) were adjusted for Group B streptococci, gestational hypertension, cervical dilation, non-elective CS, non-elective CS, uterus position, pre-CS platelet. CS, cesarean section; aOR, adjusted odds ratio. a Participants were separated into two groups based on the number of antibiotic doses administered (single dose represents only one dose and multi-dose represents more than one dose); b In the subgroup analysis of the participants, only one dose of cefradine or cefuroxime was used (total number = 352) in the regression model; all the factors were fixed except for antibiotic dosage and the same items were adjusted as above; c In the subgroup analysis of the participants (total number = 239) only cefuroxime was used in the regression model; all the factors were fixed except for antibiotic dosage and the same items were adjusted as above.
associated with intraoperative (eg emergency CS, cervical dilation, maternal intrapartum fever) or postoperative (eg fever) infections. Selection bias concerning antibiotics was therefore not well controlled.
The timing of antibiotic prophylaxis in our study was primarily upon omphalotomy, except for GBS-positive women in labor (n = 10, CSD prevalence 50%), in whom antibiotics were started upon membrane rupture or when regular uterine contractions began. Antibiotic prophylaxis before skin incision has been found to decrease the prevalence of postpartum endometritis and overall infectious morbidity in a systematic review. 23 Our results
should be evaluated further if they are in agreement with previous data.
Hypercoagulability is a physiologic complication of pregnancy; hence maintaining placental function during pregnancy and meeting delivery's hemostatic challenges, which may be a consequence of human evolution. 24 Platelet lysate has been shown to have effects on cell monolayer recovery in vitro and in the setting of wound healing in vivo. 25 We speculated that functional factors that promote wound healing may be decreased during pregnancy due to internal structural changes of platelets because CSD prevalence is negatively correlated with post-CS platelet concentration.
26
Although a higher fibrinogen concentration is beneficial in vaginal delivery, it is a predictor for CSD in women undergoing CS.
Fibrinogen increases gradually with gestational age, reaching a mean concentration of 4.5-5.4 g/L during late pregnancy (33-35 weeks). 27 We set a cut-off point at 4.5 g/L for the purposes of our study. Our findings suggest that higher fibrinogen concentrations result in the formation of larger, more stable clots that may block vessels within the myometrium and so create defects. The larger and more stable the clots are, the more space they occupy and the more time they take to break down upon uterine contraction and lochia discharge.
We found that calcium-channel blocker treatment post-CS increased CSD risk. A calcium-channel blocker (ie nifedipine) is the first-line medication for preterm labor for inhibiting uterine contractions. 28 However, administration of a calcium-channel blocker post-CS as an antihypertensive may affect wound healing and contribute to the development of CSD, in part due to the side effect of uterine contractions.
More specific factors such as intraoperative cultures of uter- By univariate analysis of the factor associated with antibiotics administration, factors with P value < 0.20 were included in the logistic regression model and the aOR is the likelihood for multi-dose antibiotics administration compared with each reference after adjustment for the factors premature rupture of membranes, pre/post-CS hemoglobin, post-CS platelet, pre-CS fibrinogen and prenatal body mass index. P value is the significant predictor analysis for multi-dose antibiotics administration by binary logistic regression adjusted with all factors simultaneously. CS, cesarean section; aOR, adjusted odds ratio.
| CON CLUS ION
Due to China's large population and high rate of cesarean delivery, the prevalence of CSD in China is high enough to warrant concern.
Perioperative infection and hypercoagulability should be considered predictors of CSD and future studies should focus on the patient-related causes of CSD.
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